P2P INTERVENTIONS™ and Pisgah Laboratories Inc

The Innovation Works To Thwart Prescription Drug Abuse By Using Abuse Deterrent APIs

API (Active Pharmaceutical Ingredient)
*The material abusers seek
to attain “Their High”

P2P INTERVENTIONS™ employs organic chemistry to entrap the API thus inhibiting its potential for abuse.

Scientists at Pisgah Labs and P2P INTERVENTIONS™ Focus Innovations To Reduce Deaths From Prescription Drug Abuse By Developing Abuse Deterrent Formulations

The end result is a pharmaceutical product suitable for pain relief with the added benefit of abuse deterrence.

Applicable to products such as Oxycontin®, Vicodin®, Ritalin®, Adderall®, Darvocet®, MS Contin®.

  • Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking

    Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking

    The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories’ abuse-deterrent technology platform as one of its Top 5 Technologies To Reduce Prescription Drug Abuse. Pisgah Laboratories’ abuse-deterrent technology lead product candidate Hydrocodone/APAP, intended to provide relief to patients in need of treatment, yet lessen the potential for drug abuse. According to …

    Read More →

Read More about P2P INTERVENTIONS™ and the technology behind Abuse Deterrent Formulations

Latest P2P INTERVENTIONS™ News - View all


Pisgah Female Doctor

Generics and Some Brands May Lose $7 Billion Pain Market as Pisgah Labs Develops Abuse Deterrent Products

As controversy surrounds the recent FDA decisions concerning abuse deterrent forms of oxycodone drug products, Pisgah Laboratories, Inc. (www.pisgahlabs.com) achieves …

Read More →
Anti Abuse Lab Doctor Web Featured

Abuse Deterrent Technology Promises Annual Budget Savings Exceeding $200 Billion

PISGAH FOREST, N.C., March 5, 2013 — Pisgah Laboratories, Inc. has announced the launch of a new website to assist …

Read More →
Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking

Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking

The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories’ abuse-deterrent technology …

Read More →

Pisgah's Interests

“Through the patented technology incorporated within P2P INTERVENTIONS™, the drug abuse epidemic can be addressed via pharmaceutical preparations inclusive of organic acid addition salts of amine-containing active pharmaceutical ingredients possessing abuse deterrent properties sufficient to reduce efficacy during illicit use. In conjunction with Pisgah Laboratories, Inc. the technology encompassed by P2P INTERVENTIONS™ is available to interested parties for licensing, co-development or purchase.” Learn more at PisgahLabs.com

P2P INTERVENTIONS™

P2P INTERVENTIONS™ | Todd Stamps 803-212-8224 | Contact By Email